Curcumin's neuroprotective efficacy in Drosophila model of idiopathic Parkinson's disease is phase specific: implication of its therapeutic effectiveness.

Phom L, Achumi B, Alone DP, Muralidhara, Yenisetti SC.

Rejuvenation Res. 2014 Dec;17(6):481-9. doi: 10.1089/rej.2014.1591.

Bilateral pallidal deep brain stimulation for X-linked dystonia-parkinsonism.

Patel AJ, Sarwar AI, Jankovic J, Viswanathan A.

World Neurosurg. 2014 Jul-Aug;82(1-2):241.e1-4. doi: 10.1016/j.wneu.2013.09.039.

Abnormal high-frequency burst firing of cerebellar neurons in rapid-onset dystonia-parkinsonism.

Fremont R, Calderon DP, Maleki S, Khodakhah K.

J Neurosci. 2014 Aug 27;34(35):11723-32. doi: 10.1523/JNEUROSCI.1409-14.2014.

The influence of instruction on arm reactions in individuals with Parkinson's disease.

Weaver TB, Adkin AL, Patterson JT, Tokuno CD.

Hum Mov Sci. 2014 Oct;37:101-10. doi: 10.1016/j.humov.2014.07.003.

Relationship between poor decision-making process and fatigue perception in Parkinson's disease patients.

Sáez-Francàs N, Hernández-Vara J, Corominas-Roso M, Alegre J, Jacas C, Casas M.

J Neurol Sci. 2014 Feb 15;337(1-2):167-72. doi: 10.1016/j.jns.2013.12.003.

Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease.

L'Episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Serapide MF, Pluchino S, Marchetti B.

Stem Cells. 2014 Aug;32(8):2147-63. doi: 10.1002/stem.1708.

Clozapine use pattern in persons with and without treatment for Parkinson's disease in real-world conditions: a naturalistic study in a community-based sample.

Verdoux H, Pambrun E.

Acta Psychiatr Scand. 2014 Dec;130(6):487-97. doi: 10.1111/acps.12344.

Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.

Hanganu A, Bedetti C, Degroot C, Mejia-Constain B, Lafontaine AL, Soland V, Chouinard S, Bruneau MA, Mellah S, Belleville S, Monchi O.

Brain. 2014 Apr;137(Pt 4):1120-9. doi: 10.1093/brain/awu036.

Association of the tumor necrosis factor -308 A/G promoter polymorphism with Tourette syndrome.

Keszler G, Kruk E, Kenezloi E, Tarnok Z, Sasvari-Szekely M, Nemoda Z.

Int J Immunogenet. 2014 Dec;41(6):493-8. doi: 10.1111/iji.12147.

Re: prospective study of restless legs syndrome and risk of erectile dysfunction.

Seftel AD.

J Urol. 2014 Jan;191(1):179-81. doi: 10.1016/j.juro.2013.10.017. No abstract available.

Ubiquilin-1 overexpression increases the lifespan and delays accumulation of Huntingtin aggregates in the R6/2 mouse model of Huntington's disease.

Safren N, El Ayadi A, Chang L, Terrillion CE, Gould TD, Boehning DF, Monteiro MJ.

PLoS One. 2014 Jan 27;9(1):e87513. doi: 10.1371/journal.pone.0087513.

Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1A.

Hettich J, Ryan SD, de Souza ON, Saraiva Macedo Timmers LF, Tsai S, Atai NA, da Hora CC, Zhang X, Kothary R, Snapp E, Ericsson M, Grundmann K, Breakefield XO, Nery FC.

Hum Mutat. 2014 Sep;35(9):1101-13. doi: 10.1002/humu.22602.

Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.

Evers MM, Toonen LJ, van Roon-Mom WM.

Mol Neurobiol. 2014 Jun;49(3):1513-31. doi: 10.1007/s12035-013-8596-2. Review.

A de novo nonsense PDGFB mutation causing idiopathic basal ganglia calcification with laryngeal dystonia.

Nicolas G, Jacquin A, Thauvin-Robinet C, Rovelet-Lecrux A, Rouaud O, Pottier C, Aubriot-Lorton MH, Rousseau S, Wallon D, Duvillard C, Béjot Y, Frébourg T, Giroud M, Campion D, Hannequin D.

Eur J Hum Genet. 2014 Oct;22(10):1236-8. doi: 10.1038/ejhg.2014.9.

Adult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticity.

Regensburger M, Prots I, Winner B.

Neural Plast. 2014;2014:454696. doi: 10.1155/2014/454696. Review.